Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.76 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HK1 | P19367 | 3/20 | 0.33 |
| ▸ | HK2 | P52789 | 3/20 | 0.33 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Metrizamide SCHEMBL16984723 | 0.87 | LMNA (1.00) | LMNAKDM4ECYP2D6CYP2C19HK1 | |
| Metrizamide SCHEMBL1650311 | 0.87 | LMNA (1.00) | LMNAKDM4ECYP2D6CYP2C19HK1 | |
| Metrizamide SCHEMBL24382 | 0.87 | LMNA (1.00) | LMNAKDM4ECYP2D6CYP2C19HK1 | |
| Metrizamide SCHEMBL11048850 | 0.87 | LMNA (1.00) | LMNAKDM4ECYP2D6CYP2C19HK1 | |
| Metrizamide SCHEMBL24383 | 0.87 | LMNA (1.00) | LMNAKDM4ECYP2D6CYP2C19HK1 | |
| Metrizamide SCHEMBL8678604 | 0.87 | LMNA (1.00) | LMNAKDM4ECYP2D6CYP2C19HK1 | |
| Iohexol SCHEMBL28086756 | 0.80 | LMNA (0.73) | LMNAKDM4ECYP2D6CYP2C19HK1 | |
| Ioversol SCHEMBL7774956 | 0.78 | LMNA (0.69) | LMNAKDM4ECYP2D6CYP2C19HK1 | |
| Metrizamide SCHEMBL17909957 | 0.76 | LMNA (0.75) | LMNAKDM4ECYP2D6CYP2C19HK1 | |
| Metrizamide SCHEMBL8373063 | 0.75 | LMNA (0.64) | LMNAKDM4ECYP2D6CYP2C19LGALS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160199464-A1 | ALGINATE AND ALGINATE LYASE COMPOSITIONS AND METHODS OF USE | UNIV JOHNS HOPKINS (US) | 2016-07-14 | — | — | US | disclosed |
| US-9220761-B2 | Alginate and alginate lyase compositions and methods of use | THE JOHN HOPKINS UNIVERSITY (US) | 2015-12-29 | — | — | US | disclosed |
| US-20130211249-A1 | DRUG ELUTING HYDROGELS FOR CATHETER DELIVERY | THE JOHNS HOPKINS UNIVERSITY (US) | 2013-08-15 | — | — | US | disclosed |
| WO-2012012772-A2 | DRUG ELUTING HYDROGELS FOR CATHETER DELIVERY | THE JOHNS HOPKINS UNIVERSITY (US) | 2012-01-26 | — | — | WO | disclosed |
| US-20110104052-A1 | METHODS OF SYNTHESIS AND USE OF CHEMOSPHERES | THE JOHNS HOPKINS UNIVERSITY (US) | 2011-05-05 | — | — | US | disclosed |
| EP-2229147-A2 | METHODS OF SYNTHESIS AND USE OF CHEMOSPHERES | The Johns Hopkins University (US) | 2010-09-22 | — | — | EP | disclosed |
| US-20100080788-A1 | ALGINATE AND ALGINATE LYASE COMPOSITIONS AND METHODS OF USE | THE JOHNS HOPKINS UNIVERSITY (US) | 2010-04-01 | — | — | US | disclosed |
| EP-2081964-A2 | ALGINATE AND ALGINATE LYASE COMPOSITIONS AND METHODS OF USE | The Johns Hopkins University (US) | 2009-07-29 | — | — | EP | disclosed |
| WO-2009073193-A2 | METHODS OF SYNTHESIS AND USE OF CHEMOSPHERES | THE JOHNS HOPKINS UNIVERSITY (US) | 2009-06-11 | — | — | WO | disclosed |
| WO-2008127290-A9 | ALGINATE AND ALGINATE LYASE COMPOSITIONS AND METHODS OF USE | UNIV JOHNS HOPKINS (US) | 2008-12-24 | — | — | WO | disclosed |
| WO-2008127290-A2 | ALGINATE AND ALGINATE LYASE COMPOSITIONS AND METHODS OF USE | THE JOHNS HOPKINS UNIVERSITY (US) | 2008-10-23 | — | — | WO | disclosed |
| US-4439613-A | Novel amino-dioxepane intermediates for the synthesis of new non-ionic contrast media | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1984-03-27 | — | — | US | disclosed |
| US-4341756-A | Novel amino-dioxepane intermediates for the synthesis of new non-ionic contrast media | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1982-07-27 | — | — | US | disclosed |